Healthcare Clinical Analytics Market to Register a Growth Rate of CAGR 6.4% During the Forecast Period 2022

The cost of providing quality healthcare is rising and this issue is faced by even the developed countries of the West. Hence providing efficient, quality and cost-effective healthcare is a priority for all. However, there is a lack of adequate funding for healthcare due to political, economic and other governance related compulsions and thus the healthcare system has to operate within this restraint.

Also, even though healthcare funding and health insurance programs exist, there is a steep increase in the cost of providing quality healthcare. Due to these reasons, healthcare providers are opting for the adoption of cost curbing tools such as healthcare clinical analytics.

Get Sample Copy of Report @https://www.persistencemarketresearch.com/samples/18607

Company Profiles

• IBM Corporation
• Cerner Corporation
• McKesson Corporation
• Allscripts Healthcare Solutions, Inc.
• Oracle Corporation
• Optum Inc.
• Medical Information Technology Inc.
• Hewlett Packard Enterprise Company
• Qsi Management LLC
• CareCloud Corporation

Get To Know Methodology of Report @https://www.persistencemarketresearch.com/methodology/18607

Due to healthcare clinical analytics, tools like big data can be used to analyze large amounts of healthcare information generated and this can be used to draw inferences and conclusions that makes the entire healthcare system efficient and transparent. Due to these factors, the global healthcare clinical analytics market is growing at a brisk pace.

The globalhealthcare clinical analytics marketis slated to touch a value of aboutUS$ 28,000 Mnin the year 2022 and grow at a robust CAGR during the assessment period.

4 Forecast Highlights on Global Healthcare Clinical Analytics Market

As per the forecast of Persistence Market Research, the integrated platform type segment is slated to touch a value of nearlyUS$ 19,000 Mnin the year 2022. This represents a robust CAGR growth during the assessment period of 2017-2022. The integrated platform type segment is estimated to account for nearly two-thirds of the revenue share of the platform type segment by the year 2017 and is forecasted to gain market share by 2022 over 2017.

Access Full Report @https://www.persistencemarketresearch.com/checkout/18607

As per the forecast of Persistence Market Research, the clinics segment will reach a value of nearlyUS$ 850 Mnin the year 2017. This represents a robust CAGR growth during the forecast period. The clinics segment is forecasted to account for nearly one-tenth of the total revenue share of the end-user segment by the end of the year 2017 and is expected to gain in market share by 2022 as compared with the year 2017.

As per the forecast of Persistence Market Research, the on-premise segment is slated to reach a value of nearlyUS$ 11,600 Mnin 2022. The on-premise segment is expected to lose market share by the end of the year 2022. The largest share is contributed by the North America region in the on-premise segment.

Persistence Market Research forecasts the in-house solution type segment to exhibit a compound annual growth rate (CAGR) of about15%from 2017 to 2022.

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Molecular Diagnostics Market –

Molecular Diagnostics MarketSegmentation by Key Players – Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.

Next-Generation Sequencing Market –

Next Generation Sequencing MarketSegmented by(By Application – Whole-genome Sequencing ,Exome Sequencing,Targeted Resequencing,De Novo Sequencing,RNA Sequencing,ChIP Sequencing,Methyl Sequencing,Others);By Technology- Targeted Sequencing & Resequencing,Whole Genome Sequencing,Whole Exome Sequencing.

Ophthalmology devises Market –

Ophthalmology devises MarketSegmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.

Intravenous Iron Drugs Market –

Intravenous (IV) Iron Drugs MarketSegmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A/S, Rockwell Medical Technologies, Inc., and Sanofi.

Syndromes Progressive Ataxia Weakness Disorders Market –

Treatments forSyndromes of Progressive Ataxia and Weakness Disorders MarketSegmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. +1-646-568-7751
E-mail id-sales@persistencemarketresearch.com
Website:https://www.persistencemarketresearch.com